Peer Reviewed Cancer Research Program
Funds innovative cancer research focused on under-addressed cancers and military health priorities to improve prevention, diagnosis, treatment, and survivorship for service members and their families.
Funder: Military Health System Research Program
Due Dates (Anticipated): May 2026: Pre-application deadline (projected) | August 2026: Full application deadline by invitation (projected)
Funding Amounts: Up to $4.5M (Clinical Trial Award, 4 yrs) | Up to $1.5M–$2M (Impact Award, 3 yrs) | Up to $600K (Idea Award, 2 yrs)
Summary: Supports innovative cancer research with military health relevance, targeting under-addressed cancers and mission readiness for service members and families.
Key Information: Pre-application (preproposal) is required; full application by invitation only.
Description
The Peer Reviewed Cancer Research Program (PRCRP) funds innovative, high-impact cancer research that addresses the unique needs of military personnel, veterans, their families, and other military beneficiaries. The program specifically supports research in cancer types not covered by other Congressionally Directed Medical Research Programs (CDMRP) cancer initiatives, emphasizing clinical relevance, military health, and mission readiness. Projects must address at least one congressionally directed cancer topic area and one military health focus area, such as environmental exposures, mission readiness, or gaps in cancer prevention, detection, diagnosis, treatment, quality of life, or survivorship. Multiple award mechanisms are available to support a range of research types, including basic, translational, and clinical research.
